Weiss Asset discloses 11.1M Avadel stake on Form 3
Avadel Pharmaceuticals received a Form 3 indicating that Weiss Asset Management LP and Andrew Weiss are reporting as ten percent owners.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Avadel Pharmaceuticals received a Form 3 indicating that Weiss Asset Management LP and Andrew Weiss are reporting as ten percent owners. The filing shows indirect beneficial ownership of 11,112,052 ordinary shares, held by two private investment funds managed by Weiss Asset Management. The reporting parties and related entities disclaim beneficial ownership except for their pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- F1. Shares reported herein represent shares beneficially owned by two private investment funds for which Weiss Asset Management LP serves as investment manager. WAM GP LLC is the general partner of Weiss Asset Management LP and Andrew Weiss is the Manager of WAM GP LLC. All of Weiss Asset Management LP, WAM GP LLC, and Andrew Weiss disclaim beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Weiss Asset Management Form 3 for AVDL disclose?
Is the Avadel (AVDL) Form 3 a buy or sell transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.